新研究揭示了一种使用纳米孔测序的简单尿液测试来检测早期卵巢癌。 New research reveals a simple urine test using nanopore sequencing for detecting early-stage ovarian cancer.

新的研究有望通过简单的尿液检测来检测早期卵巢癌，这标志着筛查这种经常被忽视的疾病的潜在突破。 New research promises a simple urine test in detecting early-stage ovarian cancer, marking a potential breakthrough in screening for the often overlooked disease. 先前的研究表明卵巢癌患者的尿液中存在特定的肽，但用于检测这些生物标志物的方法既复杂又昂贵。 Previous studies have indicated the presence of specific peptides in the urine of individuals with ovarian cancer, but the methods used to detect these biomarkers have been complex and costly. 弗吉尼亚联邦大学的一位教授发现，纳米孔测序（一种通过将遗传物质穿过小孔并监测电流波动来读取遗传物质的技术）可以用于同时检测这些肽，因此更有效。 A professor at Virginia Commonwealth University has found that nanopore sequencing, a technique that reads genetic material by passing it through a tiny hole and monitoring electric current fluctuations, could be applied to detect these peptides simultaneously, and therefore more efficiently.